Astrazeneca
IMJUDO
Manufacturer:
Astrazeneca
Name:
IMJUDO
HCPCS Code Descriptor:
Injection, tremelimumab-actl, 1 mg
Category:
C Code
HCPCS:
C9147
NDC(s):
00310-4505-25, 00310-4535-30,
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
IMJUDO is an Oncology drug manufactured by Astrazeneca and administered via the Intravenous route of administration. The C Code: C9147 is aligned to the drug IMJUDO.